Arabic Arabic English English French French German German
dark

Evasc Neurovascular Announces Enrollment of First Patient in the French eCLIPs™ Safety, Feasibility and Efficacy Study (EESIS-FR)

Evasc Neurovascular, a pioneer in the development of disruptive endovascular treatments for cerebral aneurysms, announced the enrollment of the first patient in its French eCLIPs™ Safety, Feasibility and Efficacy Study. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

BridgeBio and Amgen Unite on Combination Therapy for Advanced Solid Tumors

Next Post

FDA Approves Novel Treatment to Control Pain in Cats with Osteoarthritis, First Monoclonal Antibody Drug for Use in Any Animal Species

Related Posts
Total
0
Share